About

Hypera SA, formerly Hypermarcas SA, is a Brazil-based company engaged in the pharmaceuticals sector. The Company’s major business units include Branded Prescription, Consumer Health and Branded Generics. Branded Prescription is present in the main therapeutic classes in Brazil and it operates in the Primary Care segment under... (more)

Financials

RIO DE JANEIRO, Oct 3 The controlling
shareholder of Brazil's Hypera SA is in initial talks
about a plea deal, Brazil's Valor Economico newspaper reported
on Wednesday, as the pharmaceutical company continues an
internal probe into alleged corruption.

SAO PAULO, July 27 Quarterly profit at Hypera SA
, Brazil's largest listed producer of over-the-counter
medicine, rose 22.3 percent on a yearly basis in the second
quarter as revenues increased more than 10 percent due to higher
overall sales.

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products: